Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quasi-New Stocks

728.40
-5.1492-0.70%
Number of Gainers:64
Number of Losers:112
Number of Flat:10
PE:- -
High:740.89
Open:733.56
Low:721.57
Close:733.55
Loading ...

GH Research Submits Complete Response to FDA for Depression Treatment GH001; Shares Rise

MT Newswires Live
·
21 Jun

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week

Motley Fool
·
21 Jun

GH Research submits complete IND hold response to FDA

TIPRANKS
·
21 Jun

GH Research Submits Complete Ind Hold Response to FDA Ahead of Schedule

THOMSON REUTERS
·
21 Jun

GMS jumps after report of competing suitors, Couchbase gets bought: Morning Buzz

TIPRANKS
·
21 Jun

Rakovina Therapeutics Sets Date for Share Consolidation

TIPRANKS
·
20 Jun

European Equities Traded in the US as American Depositary Receipts Retreat Friday

MT Newswires Live
·
20 Jun

Zeta Global Up Over 13%, On Track for Largest Percent Increase Since May 2024 -- Data Talk

Dow Jones
·
20 Jun

Couchbase Up Nearly 30%, on Track for Record Percent Increase -- Data Talk

Dow Jones
·
20 Jun

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
20 Jun

Just In: MiCA Greenlight Sparks $COIN Stock Rally

CoinMarketCap
·
20 Jun

PayPoint plc Director Share Purchase Signals Confidence

TIPRANKS
·
20 Jun

Standard Chartered Sees Private Equity as Next Tokenization Boom | US Crypto News

BE[IN]CRYPTO
·
20 Jun

Coinbase Secures EU Cryptocurrency License, Moves EU Headquarters from Ireland to Luxembourg

Blockbeats
·
20 Jun

Regencell Bioscience Holdings Ltd trading halted, volatility trading pause

TIPRANKS
·
20 Jun

Zeta Global rises 12.2%

TIPRANKS
·
20 Jun

Couchbase Shares Jump 29.2% After Haveli Investments to Buy Co for $1.5 Bln

THOMSON REUTERS
·
20 Jun

In the last 24 hours, CEX net outflow of 1500.69 BTC

Blockbeats
·
20 Jun

Actuate Therapeutics Identifies Biomarkers in Treatment of Metastatic Pancreatic Cancer in Phase 2 Trial

MT Newswires Live
·
20 Jun

Couchbase jumps 28% after agreeing to be acquired for $24.50 per share

TIPRANKS
·
20 Jun